Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00433095
Status:
COMPLETED
Last Update Posted:
2011-03-14
First Post:
2007-02-07
Brief Title:
Vinorelbine Oral Plus Trastuzumab for 1st-line Treatment of HER2Neu Overexpressing Breast Cancer
Sponsor:
Organization:
Ludwig-Maximilians - University of Munich